Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON.
Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario.
J Affect Disord. 2020 Dec 1;277:55-64. doi: 10.1016/j.jad.2020.08.001. Epub 2020 Aug 8.
As a major virus outbreak in the 21st century, the Coronavirus disease 2019 (COVID-19) pandemic has led to unprecedented hazards to mental health globally. While psychological support is being provided to patients and healthcare workers, the general public's mental health requires significant attention as well. This systematic review aims to synthesize extant literature that reports on the effects of COVID-19 on psychological outcomes of the general population and its associated risk factors.
A systematic search was conducted on PubMed, Embase, Medline, Web of Science, and Scopus from inception to 17 May 2020 following the PRISMA guidelines. A manual search on Google Scholar was performed to identify additional relevant studies. Articles were selected based on the predetermined eligibility criteria.
Relatively high rates of symptoms of anxiety (6.33% to 50.9%), depression (14.6% to 48.3%), post-traumatic stress disorder (7% to 53.8%), psychological distress (34.43% to 38%), and stress (8.1% to 81.9%) are reported in the general population during the COVID-19 pandemic in China, Spain, Italy, Iran, the US, Turkey, Nepal, and Denmark. Risk factors associated with distress measures include female gender, younger age group (≤40 years), presence of chronic/psychiatric illnesses, unemployment, student status, and frequent exposure to social media/news concerning COVID-19.
A significant degree of heterogeneity was noted across studies.
The COVID-19 pandemic is associated with highly significant levels of psychological distress that, in many cases, would meet the threshold for clinical relevance. Mitigating the hazardous effects of COVID-19 on mental health is an international public health priority.
作为 21 世纪的重大病毒疫情,2019 年冠状病毒病(COVID-19)大流行给全球心理健康带来了前所未有的危害。虽然正在向患者和医护人员提供心理支持,但也需要高度关注公众的心理健康。本系统评价旨在综合现有文献,报告 COVID-19 对一般人群心理结果的影响及其相关的危险因素。
按照 PRISMA 指南,从建立到 2020 年 5 月 17 日,我们在 PubMed、Embase、Medline、Web of Science 和 Scopus 上进行了系统搜索。还在 Google Scholar 上手动搜索了其他相关研究。根据预先确定的纳入标准选择文章。
在中国、西班牙、意大利、伊朗、美国、土耳其、尼泊尔和丹麦,COVID-19 大流行期间,一般人群中报告的焦虑症状(6.33%至 50.9%)、抑郁症状(14.6%至 48.3%)、创伤后应激障碍(7%至 53.8%)、心理困扰(34.43%至 38%)和压力(8.1%至 81.9%)发生率较高。与困扰措施相关的危险因素包括女性、年龄较小(≤40 岁)、存在慢性/精神疾病、失业、学生身份以及频繁接触有关 COVID-19 的社交媒体/新闻。
研究之间存在很大程度的异质性。
COVID-19 大流行与高度显著的心理困扰有关,在许多情况下,这将达到临床相关的阈值。减轻 COVID-19 对心理健康的危害是国际公共卫生的重点。